Načítá se...
Apolipoprotein E as a Therapeutic Target in Alzheimer’s disease: A Review of Basic Research and Clinical Evidence
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder which causes progressive cognitive decline. The majority of AD cases are sporadic and late-onset (> 65 years old) making it the leading cause of dementia in the elderly. While both genetic and environmental factors contribute to...
Uloženo v:
| Vydáno v: | CNS Drugs |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526196/ https://ncbi.nlm.nih.gov/pubmed/27328687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-016-0361-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|